Floatz logo

Therapeutic Asset Ratings

615 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Humulin R
Pancretic Cancer
Fudan UniversityP2NR (0)
Ivocizumab
Adrenal Cortex Carcinoma
Fudan UniversityP2NR (0)
Ivocizumab
Skin Basal Cell Carcinoma
Fudan UniversityP2NR (0)
Ivocizumab
Malignant Germ Cell Tumor
Fudan UniversityP2NR (0)
Ivocizumab
Neoplasm With Perivascular Epithelioid Cell Differentiation
Fudan UniversityP2NR (0)
Ivocizumab
Neoplasm
Fudan UniversityP2NR (0)
Narlumosbart
Stereotactic Body Radiation Therapy (SBRT)
Fudan UniversityP2NR (0)
Shr-1701
SHR-1701
Fudan UniversityP2NR (0)
Tirelizumab
Breast Cancer
Fudan UniversityP2NR (0)
tqb2868
Hepatocellular Carcinoma，Bispecific Antibodies, HAIC, Ramucirumab
Fudan UniversityP2NR (0)
Lutetium [177Lu]-Fap-75
Neoplasm
Fudan UniversityP1NR (0)
gq1001
HER2 Positive Breast Carcinoma
Fudan UniversityP1/2NR (0)
Rgl-305
Lymphoma
Fudan UniversityN/ANR (0)
ROPIVACAINE
Intercostal Nerve Block
Fudan UniversityN/ANR (0)
ROPIVACAINE
Pulmonary Ventilation
Fudan UniversityN/ANR (0)
Showing 601 to 615 of 615 assets
PreviousPage 25 of 25Next